Canada · Series B startup

Who invested in Topigen Pharmaceuticals

2 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$24Mraised across 2 rounds since 2004, from 2 sources

$19MVenture$5.1MSeries B
Latest round
Series B, $5.1MOct 2005
Biggest round
$19MVenture · Dec 2004
Investors
6
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2005
$19MVenture$5.1MSeries B
First round
Venture, $19M
Dec 2004
Biggest round
$19M
Venture · Dec 2004
Between rounds
10 months
from the last two

The rounds

  1. Oct 2005
  2. Dec 2004

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

The exit

ExitBuyerPriceWhen
AcquiredPharmaxisundisclosedJan 2010

From historical deal records. Wrong? Tell us.

Everyone who backed them

BDC CapitalVC firm2rounds
T2C2 CapitalInvestment firm2rounds

Missing a round, or an investor who was in one? Tell us.

Quick answers about Topigen Pharmaceuticals

Who invested in Topigen Pharmaceuticals?

Topigen Pharmaceuticals's investors include BDC Capital, Desjardins Venture Capital, Fonds de solidarite Ftq, T2C2 Capital and Innovatech Grand Montreal, and 1 more on record.

How much has Topigen Pharmaceuticals raised?

Topigen Pharmaceuticals has raised $24M across 2 rounds since 2004.

When did Topigen Pharmaceuticals last raise?

Topigen Pharmaceuticals's most recent round was a Series B of $5.1M in Oct 2005.

What was Topigen Pharmaceuticals's biggest round?

Topigen Pharmaceuticals's largest round on record is $19M (Venture), in Dec 2004.

Who backed Topigen Pharmaceuticals first?

Topigen Pharmaceuticals's first round on record, in Dec 2004, was backed by BDC Capital, Desjardins Venture Capital and Fonds de solidarite Ftq and 2 others.

What stage is Topigen Pharmaceuticals at?

Topigen Pharmaceuticals's latest named round is a Series B, in Oct 2005.

Where is Topigen Pharmaceuticals based?

Topigen Pharmaceuticals is based in Canada.

Companies like Topigen Pharmaceuticals

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.